DIAGNOSIS AND MANAGEMENT OF THE AORTA | SESSION II

Tuesday, March 10, 2026

9:15 AM - 10:30 AM EST

Location: Georgetown

Moderator(s)

Steve D. Abramowitz, MD

Chair, Vascular Surgery
MedStar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure information not submitted.
Michael Siah, MD

Assistant Professor of Surgery
UT Southwestern Medical Center
Dallas, Texas, United States

Disclosure(s): Abbott, Bayer, BD, Boston Scientific, Cook, CSI, Inari, Medtronic, Philips, Shockwave and VentureMed.: Consulting Fees (e.g., advisory boards) (Ongoing); Bard Peripheral Vascular, Veryan, Biotronik, Cook Medical, Gore & Associates, Medtronic, Philips, Terumo, TriReme, Shockwave, Med Alliance, Intact Vascular, B. Braun; CSI, Boston Scientific, University of Jena, Pluristem, PQ Bypass, Surmodics, Reflow: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

J. Michael Bacharach, MD: No financial relationships to disclose

Michael Siah, MD: Abbott, Bayer, BD, Boston Scientific, Cook, CSI, Inari, Medtronic, Philips, Shockwave and VentureMed.: Consulting Fees (e.g., advisory boards) (Ongoing); Bard Peripheral Vascular, Veryan, Biotronik, Cook Medical, Gore & Associates, Medtronic, Philips, Terumo, TriReme, Shockwave, Med Alliance, Intact Vascular, B. Braun; CSI, Boston Scientific, University of Jena, Pluristem, PQ Bypass, Surmodics, Reflow: Consulting Fees (e.g., advisory boards) (Ongoing)